Plus: Cortisol levels as predictors of diabetes; AI point/counterpoint
Letter from the Editor
Almost 20 years ago Steve and I put out issue number one of DiabetesInControl. Things were a lot different then and we all had time to read a lot more information. About 10 years ago we started sending out a second weekly newsletter with a little different twist.
This week we are proud to present our 500th issue of this Tuesday’s newsletter, and in keeping with our goal of being timely and a little bit different, we are presenting Part 5 on the use of AI to manage diabetes.
We are offering a different angle from a notable physician who is not in favor of AI for managing patients. Take a look at the point/counterpoint and let me know what you think.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief |
|
|
Doctor's Option lab test products include rapid tests and CLIA certified fingerstick lab tests.
Rapid tests offer immediate test results to provide doctors with point of care test results in as little as 90 seconds.
Fingerstick lab tests provide CLIA certified lab accurate results. Each fingerstick lab test collection kit comes with a prepaid postage return envelope and everything you need to obtain and collect your fingerstick blood sample in a 510K FDA approved device.
Fingerstick lab tests are great for people who want to monitor their blood sugar, cholesterol, lipids and other important bio-markers at home or on the go.
Visit Doctor's Option |
|
|
|
|
TOP STORIES - Diabetes News and Research |
|
| Point-Counterpoint: Using Software to Determine the Best Type 2 Diabetes Treatment
In the last four issues, we discussed a new software that can go through over 6 million possible treatments using anywhere from 1 to 5 drugs for an effective treatment for type 2 diabetes. Along with determining the best treatment for the patient, it includes the ability to put in what the patient can afford in their budget. Dr. John Interlandi, one of our readers, has submitted a counterpoint to using this software to decide the best treatment options. Dr. Interlandi shares his concerns about the use of AI in medical decision making. |
| |
|
|
|
|
| | | | About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control. |
| Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com |
|
|
|
|
| | |
|
|
|
|
